Pricing
Cyanvac
Contact
No bio yet
Fred C. Davison
Chief Executive Officer
Gary Titus
Chief Financial Officer
Hong Jin
Chief Scientific Officer
Marinka Tellier
Chief Regulatory Officer
Samuel Wu
Chief Business Officer
This person is not in any teams
This person is not in any offices
Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.
Industries
Headquarters
Links
Zappos
CFK Africa
Tassat
Pipedrive
Oxford Quantum Circuits
View more